Comparative evaluation of authorized drugs for treating Covid‐19 patients

Comparative evaluation of authorized drugs for treating Covid‐19 patients

Abstract Background and Aims Vaccines are the first line of defense against coronavirus disease 2019 (Covid‐19). However, the antiviral drugs provide a new tool to fight the Covid‐19 pandemic. Here we aimed for a comparative evaluation of authorized drugs for treating Covid‐19 patients. Methods We s...

Full description

Bibliographic Details
Main Authors: Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, Md. Rabiul Islam
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Health Science Reports
Subjects:
antivirals
Covid‐19
dexamethasone
molnupiravir
monoclonal antibody
paxlovid
Online Access:https://doi.org/10.1002/hsr2.671

Internet

https://doi.org/10.1002/hsr2.671

Similar Items